Welcome!

News Feed Item

India Orthobiologics Market Outlook to 2020

NEW YORK, March 11, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

India Orthobiologics Market Outlook to 2020
http://www.reportlinker.com/p02043354/India-Orthobiologics-Market-Outlook-to-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Orthopedic

India Orthobiologics Market Outlook to 2020

Summary

GlobalData's new report, "India Orthobiologics Market Outlook to 2020", provides key market data on the India Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Orthobiologics market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
- 2012 company shares and distribution shares data for each of the market categories.
- Global corporate-level profiles of key companies operating within the India Orthobiologics market.
- Key players covered include DePuy Companies, Sanofi, Medtronic, Inc., NuVasive, Inc., Biomet, Inc., Smith & Nephew Plc, Baxter International Inc., Wright Medical Group, Inc., Stryker Corporation and Alphatec Holdings, Inc.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Orthobiologics Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Orthobiologics Market, India 7
3.1 Orthobiologics Market, India, Revenue ($m), 2005-2012 7
3.2 Orthobiologics Market, India, Revenue ($m), 2012-2020 9
3.2.1 Bone Graft Substitutes Market, India, Revenue ($m), by Segment, 2005-2012 11
3.2.2 Bone Graft Substitutes Market, India, Revenue ($m), by Segment, 2012-2020 13
3.3 Orthobiologics Market, India, Volume (Units), 2005-2012 15
3.4 Orthobiologics Market, India, Volume (Units), 2012-2020 17
3.4.1 Bone Graft Substitutes Market, India, Volume (Units), by Segment, 2005-2012 19
3.4.2 Bone Graft Substitutes Market, India, Volume (Units), by Segment, 2012-2020 21
3.5 Orthobiologics Market, India, Average Price ($), 2005-2020 23
3.6 Orthobiologics Market, India, Distribution Share by Revenue ($m), 2011-2012 25
3.7 Orthobiologics Market, India, Company Share by Revenue ($m), 2011-2012 26
4 Overview of Key Companies in India Orthobiologics Market 28
4.1 DePuy Companies 28
4.1.1 Company Overview 28
4.2 Sanofi 28
4.2.1 Company Overview 28
4.3 Baxter International Inc. 28
4.3.1 Company Overview 28
4.4 Medtronic, Inc. 29
4.4.1 Company Overview 29
4.5 Orthofix International N.V. 29
4.5.1 Company Overview 29
4.6 Biomet, Inc. 30
4.6.1 Company Overview 30
4.7 Smith & Nephew Plc 30
4.7.1 Company Overview 30
4.8 Wright Medical Group, Inc. 30
4.8.1 Company Overview 30
4.9 Stryker Corporation 31
4.9.1 Company Overview 31
5 Orthobiologics Market Pipeline Products 32
6 Financial Deals Landscape 34
6.1 Asset Transactions 34
6.1.1 Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For US$280 Million 34
6.2 Partnerships 36
6.2.1 Artimplant Enters Into Co-Marketing Agreement With Tiller International Capital 36
6.2.2 aap Implantate Enters Into Licensing Agreement With Medical Technology Company For Injectable Bone Matrix 37
7 Appendix 38
7.1 Research Methodology 39
7.1.1 Coverage 39
7.1.2 Secondary Research 39
7.1.3 Primary Research 40
7.1.4 Market Modeling and Forecasting 41
7.1.5 Company Share Analysis 44
7.1.6 Distribution Share Analysis 45
7.2 Expert Panel 46
7.3 GlobalData Consulting 46
7.4 Contact Us 46
7.5 Disclaimer 46

List of Tables

Table 1: Orthobiologics Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 8
Table 2: Orthobiologics Market, India, Revenue ($m), USD Constant, Forecast, 2012-2020 10
Table 3: Bone Graft Substitutes Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 12
Table 4: Bone Graft Substitutes Market, India, Revenue ($m), USD Constant, Forecast, 2012-2020 14
Table 5: Orthobiologics Market, India, Volume (Units), Historic, 2005-2012 16
Table 6: Orthobiologics Market, India, Volume (Units), Forecast, 2012-2020 18
Table 7: Bone Graft Substitutes Market, India, Volume (Units), Historic, 2005-2012 20
Table 8: Bone Graft Substitutes Market, India, Volume (Units), Forecast, 2012-2020 22
Table 9: Orthobiologics Market, India, Average Price ($), Historic, 2005-2012 23
Table 10: Orthobiologics Market, India, Average Price ($), Forecast, 2012-2020 24
Table 11: Orthobiologics Market, India, Distribution Share by Revenue ($m), USD Constant, 2011-2012 25
Table 12: Orthobiologics Market, India, Company Share by Revenue ($m), USD Constant, 2011-2012 27
Table 13: Orthobiologics Market Pipeline Products 32
Table 14: Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For US$280 Million 34
Table 15: Artimplant Enters Into Co-Marketing Agreement With Tiller International Capital 36
Table 16: aap Implantate Enters Into Licensing Agreement With Medical Technology Company For Injectable Bone Matrix 37
Table 17: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 41

List of Figures

Figure 1: Orthobiologics Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 7
Figure 2: Orthobiologics Market, India, Revenue ($m), USD Constant, Forecast, 2012-2020 9
Figure 3: Bone Graft Substitutes Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 11
Figure 4: Bone Graft Substitutes Market, India, Revenue ($m), USD Constant, Forecast, 2012-2020 13
Figure 5: Orthobiologics Market, India, Volume (Units), Historic, 2005-2012 15
Figure 6: Orthobiologics Market, India, Volume (Units), Forecast, 2012-2020 17
Figure 7: Bone Graft Substitutes Market, India, Volume (Units), Historic, 2005-2012 19
Figure 8: Bone Graft Substitutes Market, India, Volume (Units), Forecast, 2012-2020 21
Figure 9: Orthobiologics Market, India, Company Share (%), 2012 26
Figure 10: GlobalData Epidemiology-Based Forecasting Model 43
Figure 11: GlobalData Capital Equipment-Based Forecasting Model 44
Figure 12: Primary Interviews by Participant Type (%) 45

To order this report: India Orthobiologics Market Outlook to 2020
http://www.reportlinker.com/p02043354/India-Orthobiologics-Market-Outlook-to-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Orthopedic

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
In a recent survey, Sumo Logic surveyed 1,500 customers who employ cloud services such as Amazon Web Services (AWS), Microsoft Azure, and Google Cloud Platform (GCP). According to the survey, a quarter of the respondents have already deployed Docker containers and nearly as many (23 percent) are employing the AWS Lambda serverless computing framework. It’s clear: serverless is here to stay. The adoption does come with some needed changes, within both application development and operations. Tha...
Cloud Expo | DXWorld Expo have announced the conference tracks for Cloud Expo 2018. Cloud Expo will be held June 5-7, 2018, at the Javits Center in New York City, and November 6-8, 2018, at the Santa Clara Convention Center, Santa Clara, CA. Digital Transformation (DX) is a major focus with the introduction of DX Expo within the program. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive ov...
A strange thing is happening along the way to the Internet of Things, namely far too many devices to work with and manage. It has become clear that we'll need much higher efficiency user experiences that can allow us to more easily and scalably work with the thousands of devices that will soon be in each of our lives. Enter the conversational interface revolution, combining bots we can literally talk with, gesture to, and even direct with our thoughts, with embedded artificial intelligence, whic...
You know you need the cloud, but you're hesitant to simply dump everything at Amazon since you know that not all workloads are suitable for cloud. You know that you want the kind of ease of use and scalability that you get with public cloud, but your applications are architected in a way that makes the public cloud a non-starter. You're looking at private cloud solutions based on hyperconverged infrastructure, but you're concerned with the limits inherent in those technologies. What do you do?
Recently, REAN Cloud built a digital concierge for a North Carolina hospital that had observed that most patient call button questions were repetitive. In addition, the paper-based process used to measure patient health metrics was laborious, not in real-time and sometimes error-prone. In their session at 21st Cloud Expo, Sean Finnerty, Executive Director, Practice Lead, Health Care & Life Science at REAN Cloud, and Dr. S.P.T. Krishnan, Principal Architect at REAN Cloud, discussed how they built...
Recently, WebRTC has a lot of eyes from market. The use cases of WebRTC are expanding - video chat, online education, online health care etc. Not only for human-to-human communication, but also IoT use cases such as machine to human use cases can be seen recently. One of the typical use-case is remote camera monitoring. With WebRTC, people can have interoperability and flexibility for deploying monitoring service. However, the benefit of WebRTC for IoT is not only its convenience and interopera...
In his general session at 21st Cloud Expo, Greg Dumas, Calligo’s Vice President and G.M. of US operations, discussed the new Global Data Protection Regulation and how Calligo can help business stay compliant in digitally globalized world. Greg Dumas is Calligo's Vice President and G.M. of US operations. Calligo is an established service provider that provides an innovative platform for trusted cloud solutions. Calligo’s customers are typically most concerned about GDPR compliance, application p...
Modern software design has fundamentally changed how we manage applications, causing many to turn to containers as the new virtual machine for resource management. As container adoption grows beyond stateless applications to stateful workloads, the need for persistent storage is foundational - something customers routinely cite as a top pain point. In his session at @DevOpsSummit at 21st Cloud Expo, Bill Borsari, Head of Systems Engineering at Datera, explored how organizations can reap the bene...
With tough new regulations coming to Europe on data privacy in May 2018, Calligo will explain why in reality the effect is global and transforms how you consider critical data. EU GDPR fundamentally rewrites the rules for cloud, Big Data and IoT. In his session at 21st Cloud Expo, Adam Ryan, Vice President and General Manager EMEA at Calligo, examined the regulations and provided insight on how it affects technology, challenges the established rules and will usher in new levels of diligence arou...
Continuous Delivery makes it possible to exploit findings of cognitive psychology and neuroscience to increase the productivity and happiness of our teams. In his session at 22nd Cloud Expo | DXWorld Expo, Daniel Jones, CTO of EngineerBetter, will answer: How can we improve willpower and decrease technical debt? Is the present bias real? How can we turn it to our advantage? Can you increase a team’s effective IQ? How do DevOps & Product Teams increase empathy, and what impact does empath...
"I focus on what we are calling CAST Highlight, which is our SaaS application portfolio analysis tool. It is an extremely lightweight tool that can integrate with pretty much any build process right now," explained Andrew Siegmund, Application Migration Specialist for CAST, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
SYS-CON Events announced today that Evatronix will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Evatronix SA offers comprehensive solutions in the design and implementation of electronic systems, in CAD / CAM deployment, and also is a designer and manufacturer of advanced 3D scanners for professional applications.
SYS-CON Events announced today that Synametrics Technologies will exhibit at SYS-CON's 22nd International Cloud Expo®, which will take place on June 5-7, 2018, at the Javits Center in New York, NY. Synametrics Technologies is a privately held company based in Plainsboro, New Jersey that has been providing solutions for the developer community since 1997. Based on the success of its initial product offerings such as WinSQL, Xeams, SynaMan and Syncrify, Synametrics continues to create and hone inn...
As many know, the first generation of Cloud Management Platform (CMP) solutions were designed for managing virtual infrastructure (IaaS) and traditional applications. But that's no longer enough to satisfy evolving and complex business requirements. In his session at 21st Cloud Expo, Scott Davis, Embotics CTO, explored how next-generation CMPs ensure organizations can manage cloud-native and microservice-based application architectures, while also facilitating agile DevOps methodology. He expla...
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. In his session at @BigDataExpo, Jack Norris, Senior Vice President, Data and Applications at MapR Technologies, reviewed best practices to ...